Khan Najat bought RXRX
February 3, 2025 · Form 4 insider transaction
Khan Najat bought 420,226 shares of Recursion Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
420,226
Price
$0.00
Total value
N/A
InsiderKhan Najat
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 3, 2025
Filing dateFebruary 5, 2025
Shares owned after420,226
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.